Clinical Research Funding Scheme
Cancer Research UK's scheme supports innovative clinical and translational cancer research in the UK through modular funding for trials, experimental medicine, and sample collection.
Funder: Cancer Research UK
Due Dates: June 25, 2026 (Full application) | December 3, 2026 (Full application)
Funding Amounts: No fixed limits; typical awards: Clinical Trial module £50k–£200k/year, Experimental Medicine £100k–£300k/year, Sample Collection £30–£60/block or £5–£40/sample; up to 10 years.
Summary: Supports innovative, modular clinical and translational cancer research in the UK, with flexible funding for trials, experimental medicine, and sample collection.
Key Information: Outline application and pre-application discussion required before full submission.
Description
This scheme from Cancer Research UK funds high-quality, innovative clinical and translational cancer research through a flexible, modular structure. Researchers can apply for integrated or standalone support for Clinical Trials, Experimental Medicine, and Sample Collection modules. The scheme encourages bold, creative proposals—especially those combining trial work with mechanistic or biomarker research and sample collection. Strategic priorities include cancers of unmet need, rare cancers, and cancers in children and young people, as well as studies addressing diversity and inclusion. Rigorous peer review and robust data/sample sharing are required.
